Your browser doesn't support javascript.
loading
An HLA-G/SPAG9/STAT3 axis promotes brain metastases.
Bassey-Archibong, Blessing Iquo; Rajendra Chokshi, Chirayu; Aghaei, Nikoo; Kieliszek, Agata Monika; Tatari, Nazanin; McKenna, Dillon; Singh, Mohini; Kalpana Subapanditha, Minomi; Parmar, Arun; Mobilio, Daniel; Savage, Neil; Lam, Fred; Tokar, Tomas; Provias, John; Lu, Yu; Chafe, Shawn Christopher; Swanton, Charles; Hynds, Robert Edward; Venugopal, Chitra; Singh, Sheila Kumari.
Afiliación
  • Bassey-Archibong BI; Department of Surgery, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Rajendra Chokshi C; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Aghaei N; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Kieliszek AM; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Tatari N; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • McKenna D; Department of Surgery, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Singh M; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Kalpana Subapanditha M; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Parmar A; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Mobilio D; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Savage N; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Lam F; Department of Surgery, Division of Neurosurgery, McMaster University Faculty of Health Sciences, Hamilton General Hospital, Hamilton, ON, L8S 4K1, Canada.
  • Tokar T; Osteoarthritis Research Program, Division of Orthopedic Surgery, Schroeder Arthritis Institute, University Health Network, Toronto, ON, M5T 2S8, Canada.
  • Provias J; Data Science Discovery Centre for Chronic Diseases, Krembil Research Institute, University Health Network, Toronto, ON, M5T 2S8, Canada.
  • Lu Y; Department of Anatomical Pathology (Neuropathology), Hamilton General Hospital, Hamilton, ON, L8L 2X2, Canada.
  • Chafe SC; Department of Pathology and Molecular Medicine, Faculty of Health Sciences, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Swanton C; Department of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Hynds RE; Department of Surgery, McMaster University, Hamilton, ON, L8S 4K1, Canada.
  • Venugopal C; The Cancer Research UK (CRUK) Lung Cancer Centre of Excellence, University College London (UCL) Cancer Institute, University College London, London, WC1E 6DD, United Kingdom.
  • Singh SK; Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, NW1 1AT, United Kingdom.
Proc Natl Acad Sci U S A ; 120(8): e2205247120, 2023 02 21.
Article en En | MEDLINE | ID: mdl-36780531
Brain metastases (BM) are the most common brain neoplasm in adults. Current BM therapies still offer limited efficacy and reduced survival outcomes, emphasizing the need for a better understanding of the disease. Herein, we analyzed the transcriptional profile of brain metastasis initiating cells (BMICs) at two distinct stages of the brain metastatic cascade-the "premetastatic" or early stage when they first colonize the brain and the established macrometastatic stage. RNA sequencing was used to obtain the transcriptional profiles of premetastatic and macrometastatic (non-premetastatic) lung, breast, and melanoma BMICs. We identified that lung, breast, and melanoma premetastatic BMICs share a common transcriptomic signature that is distinct from their non-premetastatic counterparts. Importantly, we show that premetastatic BMICs exhibit increased expression of HLA-G, which we further demonstrate functions in an HLA-G/SPAG9/STAT3 axis to promote the establishment of brain metastatic lesions. Our findings suggest that unraveling the molecular landscape of premetastatic BMICs allows for the identification of clinically relevant targets that can possibly inform the development of preventive and/or more efficacious BM therapies.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias de la Mama / Antígenos HLA-G / Neoplasias Pulmonares / Melanoma Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article País de afiliación: Canadá

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Neoplasias Encefálicas / Neoplasias de la Mama / Antígenos HLA-G / Neoplasias Pulmonares / Melanoma Tipo de estudio: Prognostic_studies Límite: Adult / Humans Idioma: En Revista: Proc Natl Acad Sci U S A Año: 2023 Tipo del documento: Article País de afiliación: Canadá